HomeCompareRITPF vs JNJ

RITPF vs JNJ: Dividend Comparison 2026

RITPF yields 1.95% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RITPF wins by $381.00 in total portfolio value
10 years
RITPF
RITPF
● Live price
1.95%
Share price
$29.00
Annual div
$0.57
5Y div CAGR
23%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$2,237.92
Full RITPF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — RITPF vs JNJ

📍 RITPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRITPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RITPF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RITPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RITPF
Annual income on $10K today (after 15% tax)
$166.14/yr
After 10yr DRIP, annual income (after tax)
$1,902.23/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $2,083.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RITPF + JNJ for your $10,000?

RITPF: 50%JNJ: 50%
100% JNJ50/50100% RITPF
Portfolio after 10yr
$30.5K
Annual income
$3,463.66/yr
Blended yield
11.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RITPF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
5.9
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RITPF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRITPFJNJ
Forward yield1.95%2.13%
Annual dividend / share$0.57$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR23%28%
Portfolio after 10y$30.7K$30.3K
Annual income after 10y$2,237.92$4,689.40
Total dividends collected$9.1K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: RITPF vs JNJ ($10,000, DRIP)

YearRITPF PortfolioRITPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,940$240.41$10,592$272.30+$348.00RITPF
2$12,009$302.35$11,289$357.73+$720.00RITPF
3$13,231$381.49$12,123$472.89+$1.1KRITPF
4$14,640$483.17$13,141$629.86+$1.5KRITPF
5$16,279$614.58$14,408$846.81+$1.9KRITPF
6$18,205$785.59$16,021$1,151.60+$2.2KRITPF
7$20,489$1,009.86$18,122$1,588.22+$2.4KRITPF
8$23,229$1,306.52$20,930$2,228.20+$2.3KRITPF
9$26,558$1,702.79$24,792$3,191.91+$1.8KRITPF
10$30,655$2,237.92$30,274$4,689.40+$381.00RITPF

RITPF vs JNJ: Complete Analysis 2026

RITPFStock

RIT Capital Partners plc is a self-managed investment trust. The firm invests in the public equity and currency markets across the globe. It also invests in private investments and equity funds. The firm benchmarks the performance of its portfolio against the RPI plus 3% and MSCI All Country World Index (50% Sterling). It employs a top-down approach to make its investments. The firm makes its investments in companies operating across diversified sectors. RIT Capital Partners plc was founded on August 1, 1988 and is based in London, United Kingdom.

Full RITPF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RITPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RITPF vs SCHDRITPF vs JEPIRITPF vs ORITPF vs KORITPF vs MAINRITPF vs ABBVRITPF vs MRKRITPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.